← Back to news
Y

Yahoo Finance

Best money market account rates today, February 19, 2026 (earn up to 4.01% APY)

Y

After Years of Buybacks, Big Oil is Drilling Again

Y

TD Cowen Lowers Aurora Innovation (AUR) PT, Cites Soft 2026 Guidance Despite Growth Inflection Outlook

Y

Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery

Y

Wells Fargo Cites Legend Acquisition Uncertainty as Potential Headwind for Genius Sports (GENI) Valuation

Y

CleanSpark (CLSK): Keefe Bruyette Maintains Positive Outlook on Sealy Project Despite ERCOT Batch Study Uncertainty

Y

PagerDuty (PD): Truist Cites AI Narratives, Terminal Value Concerns as Key Drivers for Infrastructure Software

Y

BofA Lowers Teladoc (TDOC) PT on Peer Multiple Compression, Soft Sensor Tower Trends

Y

Needham Initiates Amprius Technologies (AMPX) as Key Pure-Play Unmanned Aerial Systems Supplier

Y

Is Freshworks (FRSH) One of the Best Single Digit Stocks to Buy According to Analysts?

Y

Citi Lowers Snap (SNAP) PT to $6, Cites Persistent Brand Advertising Headwinds

Y

JPMorgan Initiates TIC Solutions (TIC) Highlighting NV5 Integration and Cross-Selling Synergies

Y

Mahindra Selects Mobileye’s (MBLY) EyeQ6 ADAS for Future Vehicle Lineup

Y

Barclays Adjusts ACV Auctions (ACV) Target Amid Momentum in Used Vehicle Market

Y

Wells Fargo Cautious on Praxis Precision (PRAX) After Recent Revenue Estimates

Y

End of Apogee (APGE) Drug Collaboration Leads to Revised Analyst Expectations

Y

Morgan Stanley Positive on Cipher Mining (CIFR) Data Center Potential

Y

Analyst Bullish on Beam Therapeutics (BEAM) Over Drug Program Trajectory

Y

Vaxcyte (PCVX) $632.5M Stock Offering Follows Bullish Cantor Fitzgerald Rating

Y

Analysts Bullish on Vera Therapeutics (VERA) Amid New Commercial Chief Appointment

Y

Morgan Stanley Cautious on Nebius (NBIS) Following NVIDIA Platform Deployment

Y

TD Cowen Cautious on Amicus Therapeutics (FOLD) Despite Positive 2025 Revenue Projections

Y

ImmunityBio (IBRX) Clinical Trial for Lymphona Drug Follows $505M Convertible Note Change

Y

Critical Report on Ondas (ONDS) Precedes Defense Unit’s $30M Contract in Israel

Y

Analysts Confirm Bullish Outlook on Wave Life (WVE) Over Obesity Treatment

Y

Bullish Analyst Opinion on Dyne (DYNE) Follows Rare Disease Drug Progress in Japan

Y

Analysts Bullish on Crinetics (CRNX) Amid Positive Clinical Trial for New Drug

Y

Is This Dividend Stock a Buy Now After Falling Over 11% from Its 2026 Highs?

Y

‘The world feels unpredictable’: I’m 56. My husband is 64. Our mortgage costs $17K a month. Do we pay it off?

Y